Ata Tsh Adjustment Ch Against

---
name: ata-tsh-adjustment-ch-against
description: Recommends against using serum TSH levels to guide levothyroxine dose adjustments in patients with central hypothyroidism. Triggers include evaluating a central hypothyroidism patient on levothyroxine who requires dose adjustment.
---

# Recommend against using TSH to adjust thyroid replacement in central hypothyroidism

## STEP 1 — Gather Information
Collect serum free T4 (fT4), assess clinical symptoms of hypo- or hyperthyroidism, review pituitary disease history, note current L-T4 dose, age, estrogen status (including pregnancy), and concomitant therapies (e.g., glucocorticoids, GH) that may affect fT4 requirements.

## STEP 2 — Rule In / Rule Out
Is the hypothyroidism central (low fT4 with low/normal/mildly elevated TSH in the setting of pituitary disease)? If yes, proceed; if primary hypothyroidism is suspected (elevated TSH with low fT4), use TSH for dose adjustment per primary hypothyroidism guidelines.

## STEP 3 — Classify or Stratify
Classify fT4 level relative to target range (mid to upper half of reference range). If fT4 is below target, consider dose increase; if above target, consider dose decrease; if within target, maintain current dose.

## STEP 4 — Decide
Adjust L-T4 dose based on fT4 and clinical context, not TSH. Do not use TSH to guide dosing decisions in central hypothyroidism.

## Clinical Guardrails / Mimics / Pitfalls
Do not interpret low or undetectable TSH as overtreatment; TSH is unreliable in CH. Avoid using TSH alone to assess adequacy. Consider that TSH may be low, normal, or slightly elevated despite adequate fT4 replacement. Monitor for symptoms and fT4, not TSH.

## Concrete Clinical Example
A 50-year-old woman with pituitary macroadenoma and known central hypothyroidism is on L-T4 100 µg daily. She reports fatigue and weight gain. fT4 is low at 0.8 ng/dl (reference 0.9-1.7). TSH is 0.2 mIU/l (low). Instead of reducing dose due to low TSH, increase L-T4 to 125 µg daily based on low fT4 and symptoms, then recheck fT4 in 6 weeks.

**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, https://doi.org/10.1210/jc.2016-2118